Status:
UNKNOWN
Typical Atrial Flutter, Ablation Index and Point by Point Ablation
Lead Sponsor:
Ospedale San Francesco
Conditions:
Typical Atrial Flutter
Eligibility:
All Genders
18-90 years
Brief Summary
The Ablation of the typical atrial flutter can be considered substantially anatomical, the investigators want to test a protocol that foresees the use a lesion index (AI) and that respects the Inter-L...
Detailed Description
The Ablation of the typical atrial flutter can be considered substantially anatomical, the aim of the study is to test a protocol that foresees the use a lesion index and that respects the Inter-Lesio...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- paroxysmal, persistent and /or long standing atrial flutter even in the presence of structural heart disease
- Informed consent form
- Age equal or above 18 years
- Skilled and willing to comply with all tests and follow up requirements
- Patients that ,in the context of ablation for fibrillation atrial, should also undergo to typical flutter ablation: in this case the data collected will be those related to typical flutter ablation.
- Exclusion Criteria:
- Previous ablation for atrial flutter
- Atrial flutter secondary to electrolyte imbalance, thyroid disease or to a reversible or non-cardiac cause
- severe anemia,
- sepsis in progress
- Bypass procedure with coronary arterial artery in the last three months
- Pending cardiac transplantation or other cardiac surgery
- Pregnant or breastfeeding women
- Acute disease or active systemic infection or sepsis
- Documented left atrial thrombus
- Unstable angina
- Uncontrolled heart failure
- Life expectancy of less than 12 months
- Registration in any other study evaluating another device or medication
- Presence of intramural thrombi, tumor or other anomalies that preclude the introduction of the catheter into the vein system
Exclusion
Key Trial Info
Start Date :
February 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03867266
Start Date
February 20 2019
End Date
July 1 2019
Last Update
March 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Francesco
Nuoro, Italy, 08100